Ramaswamy Govindan

Professor of Medicine

Source: Scopus

Research output per year

If you made any changes in Pure these will be visible here soon.

27501 Citations
239 Article
59 Review article
16 Letter
11 Comment/debate
More

11 results

Filter

2020
Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples (Nature Communications, (2020), 11, 1, (4748), 10.1038/s41467-020-18151-y)
MC3 Working Group, PCAWG novel somatic mutation calling methods working group & PCAWG Consortium, Dec 2020, In: Nature communications. 11, 1, 6232.
Research output: Contribution to journal › Comment/debate

Open Access
The Mystic Role of Tumor Mutational Burden in Selecting Patients with Lung Cancer for First-Line Immunotherapy
Waqar, S. N. & Govindan, R., May 2020, In: JAMA oncology. 6, 5, p. 674-675 2 p.
Research output: Contribution to journal › Comment/debate

3 Scopus citations
2019

Biomarker-Driven Staging-Are We There Yet?
Devarakonda, S. & Govindan, R., Dec 2 2019, In: JAMA Network Open. 2, 12, p. e1917052
Research output: Contribution to journal › Comment/debate

Open Access
Erratum: The Immune Landscape of Cancer (Immunity (2018) 48(4) (812–830.e14), (S1074761318301213), (10.1016/j.immuni.2018.03.023))
The Cancer Genome Atlas Research Network, Aug 20 2019, In: Immunity. 51, 2, p. 411-412 2 p.
Research output: Contribution to journal › Comment/debate

Open Access
22 Scopus citations
Untangling the evolutionary roots of lung cancer
Devarakonda, S. & Govindan, R., Dec 1 2019, In: Nature communications. 10, 1, 2979.
Research output: Contribution to journal › Comment/debate

Open Access
3 Scopus citations
2018
Erratum: Comprehensive Characterization of Cancer Driver Genes and Mutations (ARTICLE (2018) 173(2) (371–385), (S009286741830237X), (10.1016/j.cell.2018.02.060))
The MC3 Working Group & The Cancer Genome Atlas Research Network, Aug 9 2018, In: Cell. 174, 4, p. 1034-1035 2 p.
Research output: Contribution to journal › Comment/debate

Open Access
80 Scopus citations
Erratum: The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma (Cell Reports (2018) 23(1) (313–326.e5) (S2211124718304364) (10.1016/j.celrep.2018.03.075))
The Cancer Genome Atlas Research Network, Jun 19 2018, In: Cell Reports. 23, 12, p. 3698 1 p.
Research output: Contribution to journal › Comment/debate

Open Access
36 Scopus citations
2014

Summary report from the 13^th annual targeted therapies of the treatment of lung cancer meeting
Morgensztern, D. & Govindan, R., Jan 2014, In: Clinical Lung Cancer. 15, 1, p. 16-20 5 p.
Research output: Contribution to journal › Comment/debate
2011

Erratum: Biostatistics primer: What a clinician ought to know: Hazard ratios (Journal of Thoracic Oncology (2011) 6 (978-982))
Barraclough, H., Simms, L. & Govindan, R., Aug 2011, In: Journal of Thoracic Oncology. 6, 8, p. 1454 1 p.
Research output: Contribution to journal › Comment/debate

Open Access
2010

One more fallen star-ZODIAC and its implications
Stinchcombe, T. E. & Govindan, R., Jul 1 2010, In: The Lancet Oncology. 11, 7, p. 604-605 2 p.
Research output: Contribution to journal › Comment/debate

3 Scopus citations
1997

Erratum: Practical issues in the management of the patient with small cell lung cancer (Chest Surgery Clinics of North America (February 1997) (174))
Govindan, R. & Idhe, D. C., Jan 1 1997, In: Chest Surgery Clinics of North America. 7, 3, 1 p.
Research output: Contribution to journal › Comment/debate

Search results